Hedge Fund - Paulson & Co

Hedge fund manager Kyle Bass has expanded the number of drug companies whose patents he has targeted to five.

Billionaire John Paulson’s merger strategy has gained 10 percent this year, lifted by consolidation among drugmakers.

John Paulson’s Paulson & Co had a great first quarter, achieving an average return of 5.6% from its 52 long positions in stocks with a market cap of over $1.0 billion, according to our returns methodology...

Billionaire John Paulson of Paulson & Co is a hedge fund manager, who became famous for his bets against subprime mortgages.

Hedge funds trade in and out of stocks but they also have some core holdings that they keep in their portfolios for long periods of time.

John Paulson's Paulson & Co has been having it rough for the past two years, as far as stock picking goes.

Ray Dalio’s Bridgewater Associates posted an 8.3 percent gain in January in one of its hedge funds, according to a person familiar with the matter.

DuPont plans to change the lineup of its board members — but won’t draw from the nominees proposed by the activist investor Nelson Peltz.

Hedge funds just finished one of their worst years in recent memory — but their high-paid managers are doing just fine.